ACM

Ascendant Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,000	Closed	-$1.94M	–	70
2021 Q2	$1.94M	Buy	+12,000	New	+$1.94M	1.38%	27
2021 Q1	–	Sell	-2,500	Closed	-$383K	–	66
2020 Q4	$383K	Buy	+2,500	New	+$383K	0.33%	68